The DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders
Abstract
The RAS proteins and their downstream pathways play pivotal roles in cell proliferation, differentiation, survival and cell death, but their physiological roles in human development had remained unknown. Noonan syndrome, Costello syndrome, and cardio-facio-cutaneous (CFC) syndrome are autosomal dominant multiple congenital anomaly syndromes characterized by a distinctive facial appearance, heart defects, musculocutaneous abnormalities, and mental retardation. A variety of mutations in protein tyrosine phosphatase, non-receptor type 11(PTPN11) has been identified in 50% of Noonan patients. Specific mutations in PTPN11 have been identified in LEOPARD (multiple lentigines, electrocardiographic conduction abnormalities, ocular hypertelorism, pulmonary stenosis, abnormal genitalia, retardation of growth, and sensorineural deafness) syndrome. In 2005, we discovered Harvey-RAS (HRAS) germline mutations in patients with Costello syndrome. This discovery provided a clue to identification of germline mutations in Kirsten-RAS (KRAS), BRAF and mitogen-activated protein kinase kinase 1 and 2 (MAP2K1/MAP2K2) in patients with CFC syndrome. These genes encode molecules in the RAS/RAF/MEK/extracellular signal-regulated kinase (ERK) pathway, leading to a new concept that clinically related disorders, i.e., Noonan, Costello, and CFC syndromes are caused by dysregulation of the RAS/mitogen activated protein kinase (MAPK) pathway. In the present review, we summarize mutations in HRAS, KRAS, BRAF, MAP2K1/2, and PTPN11, the phenotypes of patients with these mutations, the functional properties of mutants and animal models. Finally we suggest that disorders with mutations of molecules in the RAS/MAPK cascade (Noonan, LEOPARD, Costello, and CFC syndromes and neurofibromatosis type I) may be comprehensively termed "the RAS/MAPK syndromes." Details on mutations will be updated in the RAS/MAPK Syndromes Homepage (www.medgen.med.tohoku.ac.jp/RasMapk syndromes.html).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
Barbacid, M. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.004023 · Cited by 3,885
Targeting RAS signalling pathways in cancer therapy
Downward, J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc969 · Cited by 3,256
Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAF
Wan, P. T. C., Garnett, M. J., Roe, S. M., Lee, S., Niculescu-Duvaz, D., Good, V. M., Project, C. G., Jones, C. M., Marshall, C. J., Springer, C. J., et al. (2004) · Cell · doi:10.1016/s0092-8674(04)00215-6 · Cited by 2,808
Takai, Y., Sasaki, T., & Matozaki, T. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.1.153 · Cited by 2,475
RAS oncogenes: the first 30 years
Malumbres, M., & Barbacid, M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1097 · Cited by 1,902
Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras
Jackson, E. L., Willis, N., Mercer, K., Bronson, R. T., Crowley, D., Montoya, R., Jacks, T., & Tuveson, D. A. (2001) · Genes & Development · doi:10.1101/gad.943001 · Cited by 1,898
Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome
Tartaglia, M., Mehler, E. L., Goldberg, R., Zampino, G., Brunner, H. G., Kremer, H., van der Burgt, I., Crosby, A. H., Ion, A., Jeffery, S., et al. (2001) · Nature Genetics · doi:10.1038/ng772 · Cited by 1,733
Mechanism of activation of a human oncogene
Tabin, C. J., Bradley, S. M., Bargmann, C. I., Weinberg, R. A., Papageorge, A. G., Scolnick, E. M., Dhar, R., Lowy, D. R., & Chang, E. H. (1982) · Nature · doi:10.1038/300143a0 · Cited by 1,393
Reddy, E. P., Reynolds, R. K., Santos, E., & Barbacid, M. (1982) · Nature · doi:10.1038/300149a0 · Cited by 1,391
The ‘Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling
Neel, B. G., Gu, H., & Pao, L. (2003) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(03)00091-4 · Cited by 1,249
Somatic activation of the K-ras oncogene causes early onset lung cancer in mice
Johnson, L., Mercer, K., Greenbaum, D., Bronson, R. T., Crowley, D., Tuveson, D. A., & Jacks, T. (2001) · Nature · doi:10.1038/35074129 · Cited by 1,179
Cellular Oncogenes and Multistep Carcinogenesis
Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Science · doi:10.1126/science.6356358 · Cited by 1,127
Tartaglia, M., Niemeyer, C. M., Fragale, A., Song, X., Buechner, J., Jung, A., Hählen, K., Hasle, H., Licht, J. D., & Gelb, B. D. (2003) · Nature Genetics · doi:10.1038/ng1156 · Cited by 1,033
Complete nucleotide sequences of the T24 human bladder carcinoma oncogene and its normal homologue
Capon, D. J., Chen, E. Y., Levinson, A. D., Seeburg, P. H., & Goeddel, D. V. (1983) · Nature · doi:10.1038/302033a0 · Cited by 997
Crystal Structure of the Tyrosine Phosphatase SHP-2
Hof, P., Pluskey, S., Dhe-Paganon, S., Eck, M. J., & Shoelson, S. E. (1998) · Cell · doi:10.1016/s0092-8674(00)80938-1 · Cited by 985
Tartaglia, M., Kalidas, K., Shaw, A., Song, X., Musat, D. L., van der Burgt, I., Brunner, H. G., Bertola, D. R., Crosby, A., Ion, A., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/340847 · Cited by 802
Der, C. J., Krontiris, T. G., & Cooper, G. M. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.11.3637 · Cited by 800
Garnett, M. J., & Marais, R. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.022 · Cited by 799
Tuveson, D. A., Shaw, A. T., Willis, N. A., Silver, D. P., Jackson, E. L., Chang, S., Mercer, K. L., Grochow, R., Hock, H., Crowley, D., et al. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00085-6 · Cited by 798
The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice
Bueno, O. F. (2000) · The EMBO Journal · doi:10.1093/emboj/19.23.6341 · Cited by 774
Germline KRAS mutations cause Noonan syndrome
Schubbert, S., Zenker, M., Rowe, S. L., Böll, S., Klein, C., Bollag, G., van der Burgt, I., Musante, L., Kalscheuer, V., Wehner, L.-E., et al. (2006) · Nature Genetics · doi:10.1038/ng1748 · Cited by 730
Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid change
Taparowsky, E., Suard, Y., Fasano, O., Shimizu, K., Goldfarb, M., & Wigler, M. (1982) · Nature · doi:10.1038/300762a0 · Cited by 703
Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy
Pandit, B., Sarkozy, A., Pennacchio, L. A., Carta, C., Oishi, K., Martinelli, S., Pogna, E. A., Schackwitz, W., Ustaszewska, A., Landstrom, A., et al. (2007) · Nature Genetics · doi:10.1038/ng2073 · Cited by 698
JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis
Steelman, L. S., Pohnert, S. C., Shelton, J. G., Franklin, R. A., Bertrand, F. E., & McCubrey, J. A. (2004) · Leukemia · doi:10.1038/sj.leu.2403241 · Cited by 684
Germline mutations in HRAS proto-oncogene cause Costello syndrome
Aoki, Y., Niihori, T., Kawame, H., Kurosawa, K., Ohashi, H., Tanaka, Y., Filocamo, M., Kato, K., Suzuki, Y., Kure, S., et al. (2005) · Nature Genetics · doi:10.1038/ng1641 · Cited by 679
Self-citationOhren, J. F., Chen, H., Pavlovsky, A., Whitehead, C., Zhang, E., Kuffa, P., Yan, C., McConnell, P., Spessard, C., Banotai, C., et al. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb859 · Cited by 626
Germline gain-of-function mutations in SOS1 cause Noonan syndrome
Roberts, A. E., Araki, T., Swanson, K. D., Montgomery, K. T., Schiripo, T. A., Joshi, V. A., Li, L., Yassin, Y., Tamburino, A. M., Neel, B. G., et al. (2007) · Nature Genetics · doi:10.1038/ng1926 · Cited by 605
Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome
Niihori, T., Aoki, Y., Narumi, Y., Neri, G., Cavé, H., Verloes, A., Okamoto, N., Hennekam, R. C. M., Gillessen-Kaesbach, G., Wieczorek, D., et al. (2006) · Nature Genetics · doi:10.1038/ng1749 · Cited by 599
Self-citationGain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome
Tartaglia, M., Pennacchio, L. A., Zhao, C., Yadav, K. K., Fodale, V., Sarkozy, A., Pandit, B., Oishi, K., Martinelli, S., Schackwitz, W., et al. (2007) · Nature Genetics · doi:10.1038/ng1939 · Cited by 586
Biological properties of human c-Ha-ras1 genes mutated at codon 12
Seeburg, P. H., Colby, W. W., Capon, D. J., Goeddel, D. V., & Levinson, A. D. (1984) · Nature · doi:10.1038/312071a0 · Cited by 585
Fisher, G. H., Wellen, S. L., Klimstra, D., Lenczowski, J. M., Tichelaar, J. W., Lizak, M. J., Whitsett, J. A., Koretsky, A., & Varmus, H. E. (2001) · Genes & Development · doi:10.1101/gad.947701 · Cited by 582
Germline Mutations in Genes Within the MAPK Pathway Cause Cardio-facio-cutaneous Syndrome
Rodriguez-Viciana, P., Tetsu, O., Tidyman, W. E., Estep, A. L., Conger, B. A., Cruz, M. S., McCormick, F., & Rauen, K. A. (2006) · Science · doi:10.1126/science.1124642 · Cited by 571
Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context
Guerra, C., Mijimolle, N., Dhawahir, A., Dubus, P., Barradas, M., Serrano, M., Campuzano, V., & Barbacid, M. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00191-0 · Cited by 571
Hypertelorism With Turner Phenotype: A New Syndrome With Associated Congenital Heart Disease
Noonan, J. A. (1968) · American Journal of Diseases of Children · doi:10.1001/archpedi.1968.02100020377005 · Cited by 549
K-ras is an essential gene in the mouse with partial functional overlap with N-ras
Johnson, L., Greenbaum, D., Cichowski, K., Mercer, K., Murphy, E., Schmitt, E., Bronson, R. T., Umanoff, H., Edelmann, W., Kucherlapati, R., et al. (1997) · Genes & Development · doi:10.1101/gad.11.19.2468 · Cited by 545
Bentires-Alj, M., Paez, J. G., David, F. S., Keilhack, H., Halmos, B., Naoki, K., Maris, J. M., Richardson, A., Bardelli, A., Sugarbaker, D. J., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1923 · Cited by 509
Costello, J. (1971) · Medical Entomology and Zoology · Cited by 498
Germline gain-of-function mutations in RAF1 cause Noonan syndrome
Razzaque, M. A., Nishizawa, T., Komoike, Y., Yagi, H., Furutani, M., Amo, R., Kamisago, M., Momma, K., Katayama, H., Nakagawa, M., et al. (2007) · Nature Genetics · doi:10.1038/ng2078 · Cited by 498
Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp-2
Saxton, T. M., Henkemeyer, M., Gasca, S., Shen, R., Rossi, D. J., Shalaby, F., Feng, G.-S., & Pawson, T. (1997) · The EMBO Journal · doi:10.1093/emboj/16.9.2352 · Cited by 480
Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1–like phenotype
Brems, H., Chmara, M., Sahbatou, M., Denayer, E., Taniguchi, K., Kato, R., Somers, R., Messiaen, L., De Schepper, S., Fryns, J.-P., et al. (2007) · Nature Genetics · doi:10.1038/ng2113 · Cited by 472
Raf proteins and cancer: B-Raf is identified as a mutational target
Mercer, K. E., & Pritchard, C. A. (2003) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(03)00016-7 · Cited by 457
Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis
Loh, M. L. (2004) · Blood · doi:10.1182/blood-2003-09-3287 · Cited by 427
Grouping of Multiple-Lentigines/LEOPARD and Noonan Syndromes on the PTPN11 Gene
Digilio, M. C., Conti, E., Sarkozy, A., Mingarelli, R., Dottorini, T., Marino, B., Pizzuti, A., & Dallapiccola, B. (2002) · The American Journal of Human Genetics · doi:10.1086/341528 · Cited by 421
Araki, T., Mohi, M. G., Ismat, F. A., Bronson, R. T., Williams, I. R., Kutok, J. L., Yang, W., Pao, L. I., Gilliland, D. G., Epstein, J. A., et al. (2004) · Nature Medicine · doi:10.1038/nm1084 · Cited by 420
Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease
Tartaglia, M., Martinelli, S., Stella, L., Bocchinfuso, G., Flex, E., Cordeddu, V., Zampino, G., van der Burgt, I., Palleschi, A., Petrucci, T. C., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/499925 · Cited by 415
Three human transforming genes are related to the viral ras oncogenes.
Shimizu, K., Goldfarb, M., Suard, Y., Perucho, M., Li, Y., Kamata, T., Feramisco, J., Stavnezer, E., Fogh, J., & Wigler, M. H. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.8.2112 · Cited by 387
K-Ras is essential for the development of the mouse embryo
Koera, K., Nakamura, K., Nakao, K., Miyoshi, J., Toyoshima, K., Hatta, T., Otani, H., Aiba, A., & Katsuki, M. (1997) · Oncogene · doi:10.1038/sj.onc.1201284 · Cited by 355
Giroux, S., Tremblay, M., Bernard, D., Cardin-Girard, J.-F., Aubry, S., Larouche, L., Rousseau, S., Huot, J., Landry, J., Jeannotte, L., et al. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80164-x · Cited by 341
PTPN11 (Shp2) Mutations in LEOPARD Syndrome Have Dominant Negative, Not Activating, Effects
Kontaridis, M. I., Swanson, K. D., David, F. S., Barford, D., & Neel, B. G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513068200 · Cited by 338
Zheng, C. F., & Guan, K. L. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82142-1 · Cited by 330
Hunter, J. J., Tanaka, N., Rockman, H. A., Ross, J., & Chien, K. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.39.23173 · Cited by 312
Endothelial apoptosis in Braf-deficient mice
Wojnowski, L., Zimmer, A. M., Beck, T. W., Hahn, H., Bernal, R., Rapp, U. R., & Zimmer, A. (1997) · Nature Genetics · doi:10.1038/ng0797-293 · Cited by 299
Esteban, L. M., Vicario-Abejón, C., Fernández-Salguero, P., Fernández-Medarde, A., Swaminathan, N., Yienger, K., Lopez, E., Malumbres, M., McKay, R., Ward, J. M., et al. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.5.1444-1452.2001 · Cited by 298
Diverse Biochemical Properties of Shp2 Mutants
Keilhack, H., David, F. S., McGregor, M., Cantley, L. C., & Neel, B. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504699200 · Cited by 298
Oncogenic Ras in tumour progression and metastasis
Giehl, K. (2005) · Biological Chemistry · doi:10.1515/bc.2005.025 · Cited by 287
Shp-2 Tyrosine Phosphatase: Signaling One Cell or Many
Feng, G.-S. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4668 · Cited by 285
Analysis of the transforming potential of the human H-ras gene by random mutagenesis.
Fasano, O., Aldrich, T., Tamanoi, F., Taparowsky, E., Furth, M., & Wigler, M. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.13.4008 · Cited by 280
Bailleul, B., Surani, M. A., White, S., Barton, S. C., Brown, K., Blessing, M., Jorcano, J., & Balmain, A. (1990) · Cell · doi:10.1016/0092-8674(90)90115-u · Cited by 277
The role of Shp2 (PTPN11) in cancer
Mohi, M. G., & Neel, B. G. (2007) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2006.12.011 · Cited by 274
PTPN11 mutations in LEOPARD syndrome
Legius, E., Schrander-Stumpel, C., Schollen, E., Pulles-Heintzberger, C., Gewillig, M., & Fryns, J.-P. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.8.571 · Cited by 274
Chan, I. T., Kutok, J. L., Williams, I. R., Cohen, S., Kelly, L., Shigematsu, H., Johnson, L., Akashi, K., Tuveson, D. A., Jacks, T., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20476 · Cited by 270
Lu, W., Gong, D., Bar-Sagi, D., & Cole, P. A. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00369-0 · Cited by 268
Kratz, C. P. (2005) · Blood · doi:10.1182/blood-2005-02-0531 · Cited by 267
Genotype-phenotype correlations in Noonan syndrome
Zenker, M., Buheitel, G., Rauch, R., Koenig, R., Bosse, K., Kress, W., Tietze, H.-U., Doerr, H.-G., Hofbeck, M., Singer, H., et al. (2004) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2003.11.032 · Cited by 249
Genotype-phenotype correlation in Costello syndrome: HRAS mutation analysis in 43 cases
Kerr, B., Delrue, M.-A., Sigaudy, S., Perveen, R., Marche, M., Burgelin, I., Stef, M., Tang, B., Eden, O. B., O’Sullivan, J., et al. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2005.040352 · Cited by 231
Carta, C., Pantaleoni, F., Bocchinfuso, G., Stella, L., Vasta, I., Sarkozy, A., Digilio, C., Palleschi, A., Pizzuti, A., Grammatico, P., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/504394 · Cited by 225
Reynolds, J. F., Neri, G., Herrmann, J. P., Blumberg, B., Coldwell, J. G., Miles, P. V., Opitz, J. M., & Carey, J. C. (1986) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320250303 · Cited by 217
Costello syndrome: An overview
Hennekam, R. C. M. (2003) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.10019 · Cited by 213
Sarkozy, A., Conti, E., Seripa, D., Digilio, M. C., Grifone, N., Tandoi, C., Fazio, V. M., Di Ciommo, V, Marino, B., Pizzuti, A., et al. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.9.704 · Cited by 203
Expansion of the genotypic and phenotypic spectrum in patients with KRAS germline mutations
Zenker, M., Lehmann, K., Schulz, A. L., Barth, H., Hansmann, D., Koenig, R., Korinthenberg, R., Kreiss-Nachtsheim, M., Meinecke, P., Morlot, S., et al. (2007) · Journal of Medical Genetics · doi:10.1136/jmg.2006.046300 · Cited by 202
Meuwissen, R., Linn, S. C., van der Valk, M., Mooi, W. J., & Berns, A. (2001) · Oncogene · doi:10.1038/sj.onc.1204837 · Cited by 200
A New Syndrome: Mental Subnormality and Nasal Papillomata
COSTELLO, J. M. (1977) · Journal of Paediatrics and Child Health · doi:10.1111/j.1440-1754.1977.tb01135.x · Cited by 195
Fragale, A., Tartaglia, M., Wu, J., & Gelb, B. D. (2004) · Human Mutation · doi:10.1002/humu.20005 · Cited by 194
Tumor predisposition in Costello syndrome
Gripp, K. W. (2005) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.30065 · Cited by 193
HRAS mutation analysis in Costello syndrome: Genotype and phenotype correlation
Gripp, K. W., Lin, A. E., Stabley, D. L., Nicholson, L., Scott, C. I., Doyle, D., Aoki, Y., Matsubara, Y., Zackai, E. H., Lapunzina, P., et al. (2006) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31047 · Cited by 191
Self-citationKushner, S. A., Elgersma, Y., Murphy, G. G., Jaarsma, D., van Woerden, G. M., Hojjati, M. R., Cui, Y., LeBoutillier, J. C., Marrone, D. F., Choi, E. S., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2836-05.2005 · Cited by 186
Mek2 Is Dispensable for Mouse Growth and Development
Bélanger, L.-F., Roy, S., Tremblay, M., Brott, B., Steff, A.-M., Mourad, W., Hugo, P., Erikson, R., & Charron, J. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.14.4778-4787.2003 · Cited by 181
Estep, A. L., Tidyman, W. E., Teitell, M. A., Cotter, P. D., & Rauen, K. A. (2006) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31078 · Cited by 180
Mercer, K., Giblett, S., Green, S., Lloyd, D., DaRocha Dias, S., Plumb, M., Marais, R., & Pritchard, C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2211 · Cited by 179
Binder, G., Neuer, K., Ranke, M. B., & Wittekindt, N. E. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0995 · Cited by 177
Musante, L., Kehl, H. G., Majewski, F., Meinecke, P., Schweiger, S., Gillessen-Kaesbach, G., Wieczorek, D., Hinkel, G. K., Tinschert, S., Hoeltzenbein, M., et al. (2003) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200935 · Cited by 163
Clinical and molecular analysis of 30 patients with multiple lentigines LEOPARD syndrome
Sarkozy, A., Conti, E., Digilio, M. C., Marino, B., Morini, E., Pacileo, G., Wilson, M., Calabrò, R., Pizzuti, A., & Dallapiccola, B. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2003.013466 · Cited by 159
Gripp, K. W., Scott, C. I., Nicholson, L., McDonald‐McGinn, D. M., Ozeran, J. D., Jones, M. C., Lin, A. E., & Zackai, E. H. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10241 · Cited by 156
Germ-line and somatic PTPN11 mutations in human disease
Tartaglia, M., & Gelb, B. D. (2005) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2005.03.001 · Cited by 141
Noonan Syndrome: Relationships between Genotype, Growth, and Growth Factors
Limal, J. M., Parfait, B., Cabrol, S., Bonnet, D., Leheup, B., Lyonnet, S., Vidaud, M., & Bouc, Y. L. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0983 · Cited by 138
Functional analysis of PTPN11/SHP-2 mutants identified in Noonan syndrome and childhood leukemia
Niihori, T., Aoki, Y., Ohashi, H., Kurosawa, K., Kondoh, T., Ishikiriyama, S., Kawame, H., Kamasaki, H., Yamanaka, T., Takada, F., et al. (2005) · Journal of Human Genetics · doi:10.1007/s10038-005-0239-7 · Cited by 136
Self-citationZampino, G., Pantaleoni, F., Carta, C., Cobellis, G., Vasta, I., Neri, C., Pogna, E. A., Feo, E. D., Delogu, A. B., Sárközy, A., et al. (2006) · Human Mutation · doi:10.1002/humu.20431 · Cited by 134
Heumann, R., Goemans, C. G., Bartsch, D., Lingenhöhl, K., Waldmeier, P. C., Hengerer, B., ALLEGRINI, P. R., Schellander, K., Wagner, E. F., Arendt, T., et al. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.151.7.1537 · Cited by 128
Kosaki, K., Suzuki, T. A., Muroya, K., Hasegawa, T., Sato, S., Matsuo, N., Kosaki, R., Nagai, T., Hasegawa, Y., & Ogata, T. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.8.8694 · Cited by 125
Ras signaling from plasma membrane and endomembrane microdomains
Plowman, S. J., & Hancock, J. F. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2005.06.004 · Cited by 124
Loh, M. L., Reynolds, M. G., Vattikuti, S., Gerbing, R. B., Alonzo, T. A., Carlson, E. J., Cheng, J. W., Lee, C. M., Lange, B. J., & Meshinchi, S. (2004) · Leukemia · doi:10.1038/sj.leu.2403492 · Cited by 121
Reduced phosphatase activity of SHP‐2 in LEOPARD syndrome: Consequences for PI3K binding on Gab1
Hanna, N., Montagner, A., Lee, W. H., Miteva, M. A., Vidal, M., Vidaud, M., Parfait, B., & Raynal, P. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.03.088 · Cited by 117
Yoshida, R. Y., Hasegawa, T., Hasegawa, Y., Nagai, T., Kinoshita, E., Tanaka, Y., Kanegane, H., Ohyama, K., Onishi, T., Hanew, K., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032091 · Cited by 111
Regulation of Long-Term Potentiation by H-Ras through NMDA Receptor Phosphorylation
Manabe, T., Aiba, A., Yamada, A., Ichise, T., Sakagami, H., Kondo, H., & Katsuki, M. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-07-02504.2000 · Cited by 110
Narumi, Y., Aoki, Y., Niihori, T., Neri, G., Cavé, H., Verloès, A., Nava, C., Kavamura, M. I., Okamoto, N., Kurosawa, K., et al. (2007) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31658 · Cited by 107
Self-citationCostello syndrome: Phenotype, natural history, differential diagnosis, and possible cause
Johnson, J. P., Golabi, M., Norton, M. E., Rosenblatt, R. M., Feldman, G. M., Yang, S. P., Hall, B. D., Fries, M. H., & Carey, J. C. (1998) · The Journal of Pediatrics · doi:10.1016/s0022-3476(98)70284-7 · Cited by 105
Expression of the H-ras proto-oncogene is controlled by alternative splicing
Cohen, J. B., Broz, S. D., & Levinson, A. D. (1989) · Cell · doi:10.1016/0092-8674(89)90427-3 · Cited by 105
Insulin Signaling in Mice Expressing Reduced Levels of Syp
Arrandale, J. M., Gore-Willse, A., Rocks, S., Ren, J.-M., Zhu, J., Davis, A. C., Livingston, J. N., & Rabin, D. U. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.35.21353 · Cited by 101
Ferreira, L. V., Souza, S. A. L., Arnhold, I. J. P., Mendonca, B. B., & Jorge, A. A. L. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2559 · Cited by 100
Somatic mosaicism for an HRAS mutation causes Costello syndrome
Gripp, K. W., Stabley, D. L., Nicholson, L., Hoffman, J. D., & Sol‐Church, K. (2006) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31456 · Cited by 97
Hobbs, R. M., Silva-Vargas, V., Groves, R. W., & Watt, F. M. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.23225.x · Cited by 92
PTPN11 Mutations in Noonan syndrome type I: detection of recurrent mutations in exons 3 and 13
Maheshwari, M., Belmont, J. W., Fernbach, S. D., Ho, T., Molinari, L., Yakub, I., Yu, F., Combes, A., Towbin, J. A., Craigen, W. J., et al. (2002) · Human Mutation · doi:10.1002/humu.10129 · Cited by 89
PTPN11 mutations in patients with LEOPARD syndrome: a French multicentric experience
Keren, B., Hadchouel, A., Saba, S., Sznajer, Y., Bonneau, D., Leheup, B., Boute, O., Gaillard, D. A., Lacombe, D., Layet, V., et al. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2004.021451 · Cited by 88
Loh, M. L., Martinelli, S., Cordeddu, V., Reynolds, M. G., Vattikuti, S., Lee, C. M., Wulfert, M., Germing, U., Haas, P. S., Niemeyer, C. M., et al. (2004) · Leukemia Research · doi:10.1016/j.leukres.2004.10.001 · Cited by 65
Paternal bias in parental origin ofHRASmutations in Costello syndrome
Sol‐Church, K., Stabley, D. L., Nicholson, L., Gonzalez, I. L., & Gripp, K. W. (2006) · Human Mutation · doi:10.1002/humu.20381 · Cited by 65
Coordinate Regulation of STAT Signaling and c-fosExpression by the Tyrosine Phosphatase SHP-2
Servidei, T., Aoki, Y., Lewis, S. E., Symes, A. J., Fink, J. S., & Reeves, S. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.11.6233 · Cited by 65
Self-citationNeri, G., Zollino, M., & Reynolds, J. F. (1991) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320390323 · Cited by 59
PTPN11 Gene Analysis in 74 Brazilian Patients with Noonan Syndrome or Noonan-like Phenotype
Bertola, D. R., Pereira, A. C., Albano, L. M. J., de Oliveira, P. S. L., Kim, C. A., & Krieger, J. E. (2006) · Genetic Testing · doi:10.1089/gte.2006.10.186 · Cited by 58
Absence of PTPN11 mutations in 28 cases of cardiofaciocutaneous (CFC) syndrome
Ion, A., Tartaglia, M., Song, X., Kalidas, K., van der Burgt, I., Shaw, A. C., Ming, J. E., Zampino, G., Zackai, E. H., Dean, J., et al. (2002) · Human Genetics · doi:10.1007/s00439-002-0803-6 · Cited by 51
Hepatoblastoma and heart transplantation in a patient with cardio‐facio‐cutaneous syndrome
Al‐Rahawan, M. M., Chute, D. J., Sol‐Church, K., Gripp, K. W., Stabley, D. L., McDaniel, N. L., Wilson, W. G., & Waldron, P. E. (2007) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31819 · Cited by 47
Wieczorek, D., Majewski, F., & Giliessen‐Kaesbach, G. (1997) · Clinical Genetics · doi:10.1111/j.1399-0004.1997.tb02512.x · Cited by 46
Takahashi, K., Kogaki, S., Kurotobi, S., Nasuno, S., Ohta, M., Okabe, H., Wada, K., Sakai, N., Taniike, M., & Ozono, K. (2005) · European Journal of Pediatrics · doi:10.1007/s00431-005-1679-y · Cited by 45
Guil, S., de la Iglesia, N., Fernández-Larrea, J., Cifuentes, D., Ferrer, J. C., Guinovart, J. J., & Bach‐Elias, M. (2003) · PubMed · Cited by 44
PTPN11 mutations are not responsible for the Cardiofaciocutaneous (CFC) syndrome
Kavamura, M. I., Pomponi, M. G., Zollino, M., Lecce, R., Murdolo, M., Brunoni, D., Alchorne, M. M. A., Opitz, J. M., & Neri, G. (2003) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200911 · Cited by 40
Acute lymphoblastic leukaemia in a patient with cardiofaciocutaneous syndrome
BERG, H. V. D., & Hennekam, R. C. M. (1999) · Journal of Medical Genetics · doi:10.1136/jmg.36.10.799 · Cited by 39
Rauen, K. A. (2006) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31315 · Cited by 36
PTPN11 mutation in a large family with Noonan syndrome and dizygous twinning
Schollen, E., Matthijs, G., Gewillig, M. H. M. L., Fryns, J., & Legius, E. (2003) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200915 · Cited by 34
Yoshida, R. Y., Miyata, M., Nagai, T., Yamazaki, T., & Ogata, T. (2004) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30029 · Cited by 34
Two novel and one recurrent PTPN11 mutations in LEOPARD syndrome
Yoshida, R. Y., Nagai, T., Hasegawa, T., Kinoshita, E., Tanaka, T., & Ogata, T. (2004) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30281 · Cited by 32
Recurring HRAS mutation G12S in Dutch patients with Costello syndrome
Steensel, M. A. M. V., Vreeburg, M., Peels, C. H., van Ravenswaaij‐Arts, C. M. A., Bijlsma, E. K., Schrander-Stumpel, C. T. R. M., & Steensel, M. A. M. V. (2006) · Experimental Dermatology · doi:10.1111/j.1600-0625.2006.00474.x · Cited by 31
Mild variable Noonan syndrome in a family with a novel PTPN11 mutation
Zenker, M., Voß, E., & Reis, A. (2006) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2006.08.003 · Cited by 21
Cited by
Pathological roles of MAPK signaling pathways in human diseases
Kim, E. K., & Choi, E.-J. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.12.009 · Cited by 2,472
Molecular Basis of Colorectal Cancer
Markowitz, S. D., & Bertagnolli, M. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804588 · Cited by 2,052
Ras in Cancer and Developmental Diseases
Fernandez-Medarde, A., & Santos, E. (2011) · Genes & Cancer · doi:10.1177/1947601911411084 · Cited by 897
Rose, B. A., Force, T., & Wang, Y. (2010) · Physiological Reviews · doi:10.1152/physrev.00054.2009 · Cited by 723
Keshet, Y., & Seger, R. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60761-795-2_1 · Cited by 642
Metadata
- Authors
- Aoki, Y., Niihori, T., Narumi, Y., Kure, S., & Matsubara, Y.
- Venue
- Human Mutation
- Publisher
- Wiley
- Published
- 2008-08
- Volume
- 29
- Issue
- 8
- Pages
- 992-1006
- ISSN
- 1059-7794 (ISSN-L)
- 1098-1004
- OpenAlex
- W1982232165
- Cited by
- 365
- References
- 123
- FWCI
- 14.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.